Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The decrease in mood homeostasis due to lockdown translates (in simulations) into 3 times more episodes of depressed mood, according to a study, published in JAMA Psychiatry, led by Dr Maxime Taquet, University of Oxford.

Image of the globe with a padlock over it - symbolising lock-down, reinforced by COVID-19 molecules around the globe.

This new study, Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands, shows how changes in mood homeostasis (natural mood regulation) using interventions could provide a fruitful avenue to mitigate the impact of the COVID-19 pandemic on people's mental health.

 

Vulnerable people with a history of mental illness are particularly affected and this study shows the larger the decrease in mood homeostasis during the lockdown, the larger the decrease in overall mood.Dr Maxime Taquet, Academic Foundation Doctor, University of Oxford.

 

Dr Maxime Taquet, lead author of the study, explains, 'This study follows on from a larger study where we looked at 58,328 participants from low, middle and high income countries, comparing people with low mood, or a history of depression with those of high mood. Both studies suggest that interventions which target mood homeostasis might help lift mood and prevent depression.'

Full study on: Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands

To read the earlier study, Mood homeostasis, low mood, and history of depression in 2 large population samples.

 

 

 

 

 

 

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New Research Presented at the ECNP Conference - October 2021

Dr Angharad de Cates and Dr Liliana Capitão were just two of the department's researchers presenting and publishing new research at the European College of Neuropsychopharmacology (ECNP) Conference 2021, in Lisbon.

Researchers Address Mental Health Effects of the Pandemic on Young People

In a new policy briefing, a team of researchers at King’s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK through their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.

Turing Fellowships for Over 30 Oxford Academics

Professor John Geddes, WA Handley-elect Chair of Psychiatry, is one of the thirty-three University of Oxford researchers, which have been named Turing Fellows for the 2021/22 academic year.

Simple Intervention Effectively Treats Depression During COVID 19

New research shows that even a very simple intervention, administered by non-specialists with just 15 hours of training, can effectively treat depression during COVID-19.

Over a Third of COVID-19 Patients Diagnosed with at Least One Long-COVID Symptom

A new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.